Fischer, J. C.;Lin, C. -C;Heidegger, S.;Wintges, A.;Schlapschy, M.;Beudert, M.;Combs, S. E.;Bassermann, F.;Skerra, A.;Haas, T.;Poeck, H..No improved Regeneration after radiogenic and immunopathogenic Tissue Damage by Type III Interferon Activation.Strahlenther Onkol.2019.195 Suppl 1.S166-S166

Chung, Liam;Thiele Orberg, Erik;Geis, Abby L;Chan, June L;Fu, Kai;DeStefano Shields, Christina E;Dejea, Christine M;Fathi, Payam;Chen, Jie;Finard, Benjamin B;Tam, Ada J;McAllister, Florencia;Fan, Hongni;Wu, Xinqun;Ganguly, Sudipto;Lebid, Andriana;Metz, Paul;Van Meerbeke, Sara W;Huso, David L;Wick, Elizabeth C;Pardoll, Drew M;Wan, Fengyi;Wu, Shaoguang;Sears, Cynthia L;Housseau, Franck.Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells..Cell Host Microbe.2018.23.2.203-214.e5

Al-Batran, Salah-Eddin;Pauligk, Claudia;Goetze, Thorsten Oliver;Riera-Knorrenschild, Jorge;Goekkurt, Eray;Angermeier, Stefan;Kullmann, Frank;Thuss-Patience, Peter C.;Homann, Nils;Ettrich, Thomas Jens;Junge, Sabine;Hofheinz, Ralf;Lorenzen, Sylvie.Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase 2 trial of the German Gastric Group of the AIO..J Clin Oncol.2019.37 Suppl S.15

Engel-Riedel, Walburga;Lowe, Jamie;Mattson, Paulette;Richard Trout, J;Huhn, Richard D;Gargano, Michele;Patchen, Myra L;Walsh, Richard;Trinh, My My;Dupuis, Mariève;Schneller, Folker.A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer..J Immunother Cancer.2018.6.1

Heidegger, Simon;Wintges, Alexander;Stritzke, Florian;Steiger, Katja;Koenig, Paul-Albert;Engleitner, Thomas;Fischer, Julius Clemens;Makarov, Vladimir;Winter, Christof;Rad, Roland;van den Brink, Marcel R. M.;Ruland, Juergen;Bassermann, Florian;Chan, Timothy;Haas, Tobias;Poeck, Hendrik.RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade.Blood.2019.134 Suppl 1

Thiele Orberg, E;Fan, H;Tam, A J;Dejea, C M;Destefano Shields, C E;Wu, S;Chung, L;Finard, B B;Wu, X;Fathi, P;Ganguly, S;Fu, J;Pardoll, D M;Sears, C L;Housseau, F.The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis..Mucosal Immunol.2017.10.2.421-433

Reim, Daniel;Novotny, Alexander;Friess, Helmut;Slotta-Huspenina, Julia;Weichert, Wilko;Ott, Katja;Dislich, Bastian;Lorenzen, Sylvie;Becker, Karen;Langer, Rupert.Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas..J Pathol Clin Res.2020.6.4.263-272

Biederstädt, Alexander;Hassan, Zonera;Schneeweis, Christian;Schick, Markus;Schneider, Lara;Muckenhuber, Alexander;Hong, Yingfen;Siegers, Gerrit;Nilsson, Lisa;Wirth, Matthias;Dantes, Zahra;Steiger, Katja;Schunck, Kathrin;Langston, Steve;Lenhof, H-P;Coluccio, Andrea;Orben, Felix;Slawska, Jolanta;Scherger, Anna;Saur, Dieter;Müller, Stefan;Rad, Roland;Weichert, Wilko;Nilsson, Jonas;Reichert, Maximilian;Schneider, Günter;Keller, Ulrich.SUMO pathway inhibition targets an aggressive pancreatic cancer subtype..Gut.2020.69.8.1472-1482

Ettrich, Thomas J;Ebert, Matthias;Lorenzen, Sylvie;Moehler, Markus;Vogel, Arndt;Witkowski, Lukas;Seufferlein, Thomas;Reinacher-Schick, Anke.[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]..Z Gastroenterol.2018.56.4.384-397

Schoeppe, Franziska;Sommer, Wieland H;Nörenberg, Dominik;Verbeek, Mareike;Bogner, Christian;Westphalen, C Benedikt;Dreyling, Martin;Rummeny, Ernst J;Fingerle, Alexander A.Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphoma..Eur Radiol.2018.28.9.3702-3709